Optimized gene editing for treating ALS through compact RNA-guided nucleases

Acrobat Genomics is advancing CRISPR/Cas technology to treat ALS by developing compact RNA-guided nucleases. This approach targets the genetic driver C9ORF72, aiming to enhance gene editing efficiency and reduce neurotox...